Identification and analysis of mutational hotspots in oncogenes and tumour suppressors

Supplementary Materials
Using the caret library in R we applied a 10-fold cross validation on a polynomial kernel support vector machine (SVM) to optimise and train a classifier to predict whether a known cancer driver gene is an oncogene or a tumour suppressor. We used the domains in the gene's protein product as the features. This feature space is not exclusive: 44 protein domains are observed in tumour suppressors and oncogenes. The number of oncogenes and tumour suppressors were balanced in the training set.
A gridsearch for optimised hyperparameters at cross validation found the optimised model (Degree = 2, scale = 1, C = 4) achieved a ROC AUC score of 0.72.
Using the optimised model we made predictions for a set of genes that have been reported to act as both tumour suppressor and oncogenes We found that 17 of the genes were predicted to be tumour suppressors, including TP53, DAXX and DDB2 with probabilities of greater than 0.94. Nine genes were classified as oncogenes including ERBB4, BCL10 and BTK with probabilities around 0.90, and 11 could not be resolved using this approach. The significant domains in tumour suppressors are listed by the Pfam domain name, the number of domains, the mutation enrichment expressed as the ratio of the observed number of domain mutations to the expected number of mutation, the Bonferroni corrected p-value and the gene names. The list sorted by enrichment score followed by the number of domains. *Indicates that the initial p-value was calculated using Fisher's exact test. The significant domains in tumour suppressors are listed by the Pfam domain name, the number of domains, the mutation enrichment expressed as the ratio of the observed number of domain mutations to the expected number of mutation, the Bonferroni corrected p-value and the gene names. The list sorted by enrichment score followed by the number of domains. *Indicates that the initial p-value was calculated using Fisher's exact test.
Gene
Supplementary
